Cargando…
Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most recent compounds are based on a highly flexible tertiar...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048867/ https://www.ncbi.nlm.nih.gov/pubmed/33369214 http://dx.doi.org/10.1002/cmdc.202000822 |
_version_ | 1783679313518788608 |
---|---|
author | Tan, Kathrin Jäger, Christian Körschgen, Hagen Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Stöcker, Walter Ramsbeck, Daniel |
author_facet | Tan, Kathrin Jäger, Christian Körschgen, Hagen Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Stöcker, Walter Ramsbeck, Daniel |
author_sort | Tan, Kathrin |
collection | PubMed |
description | Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most recent compounds are based on a highly flexible tertiary amine scaffold that could cause metabolic liabilities or decreased potency due to the entropic penalty upon binding to the target. Thus, the aim of this study was to discover novel conformationally constrained scaffolds as starting points for further inhibitor optimization. Shifting from flexible tertiary amines to rigid heteroaromatic cores resulted in a boost in inhibitory activity. Moreover, some compounds already exhibited higher activity against individual astacin proteinases compared to recently reported inhibitors and also a favorable off‐target selectivity profile, thus qualifying them as very suitable chemical probes for target validation. |
format | Online Article Text |
id | pubmed-8048867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80488672021-04-20 Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach Tan, Kathrin Jäger, Christian Körschgen, Hagen Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Stöcker, Walter Ramsbeck, Daniel ChemMedChem Full Papers Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most recent compounds are based on a highly flexible tertiary amine scaffold that could cause metabolic liabilities or decreased potency due to the entropic penalty upon binding to the target. Thus, the aim of this study was to discover novel conformationally constrained scaffolds as starting points for further inhibitor optimization. Shifting from flexible tertiary amines to rigid heteroaromatic cores resulted in a boost in inhibitory activity. Moreover, some compounds already exhibited higher activity against individual astacin proteinases compared to recently reported inhibitors and also a favorable off‐target selectivity profile, thus qualifying them as very suitable chemical probes for target validation. John Wiley and Sons Inc. 2020-12-23 2021-03-18 /pmc/articles/PMC8048867/ /pubmed/33369214 http://dx.doi.org/10.1002/cmdc.202000822 Text en © 2020 The Authors. ChemMedChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full Papers Tan, Kathrin Jäger, Christian Körschgen, Hagen Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Stöcker, Walter Ramsbeck, Daniel Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach |
title | Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach |
title_full | Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach |
title_fullStr | Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach |
title_full_unstemmed | Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach |
title_short | Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach |
title_sort | heteroaromatic inhibitors of the astacin proteinases meprin α, meprin β and ovastacin discovered by a scaffold‐hopping approach |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048867/ https://www.ncbi.nlm.nih.gov/pubmed/33369214 http://dx.doi.org/10.1002/cmdc.202000822 |
work_keys_str_mv | AT tankathrin heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT jagerchristian heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT korschgenhagen heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT geisslerstefanie heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT schlenzigdagmar heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT buchholzmirko heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT stockerwalter heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach AT ramsbeckdaniel heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach |